Lipoxygenase modulation to reverse carcinogenesisSHUREIQI, Imad; LIPPMAN, Scott M.Cancer research (Baltimore). 2001, Vol 61, Num 17, pp 6307-6312, issn 0008-5472Article

The convergent development of molecular-targeted drugs for cancer treatment and preventionLIPPMAN, Scott M; HEYMACH, John V.Clinical cancer research. 2007, Vol 13, Num 14, pp 4035-4041, issn 1078-0432, 7 p.Article

Protease inhibitors in oral carcinogenesis and chemopreventionLIPPMAN, Scott M; MATRISIAN, Lynn M.Clinical cancer research. 2000, Vol 6, Num 12, pp 4599-4603, issn 1078-0432Article

Cancer prevention by delay: Commentary re : J. A. O'Shaughnessy et al., Treatment and prevention of intraepithelial neoplasia : An important target for accelerated new agent development. clin. cancer res., 8 : 314-346, 2002LIPPMAN, Scott M; HONG, Waun Ki.Clinical cancer research. 2002, Vol 8, Num 2, pp 305-313, issn 1078-0432Article

Reducing the risk of chemoprevention : Defining and targeting high risk-2005 AACR cancer research and prevention foundation award lectureLIPPMAN, Scott M; LEE, J. Jack.Cancer research (Baltimore). 2006, Vol 66, Num 6, pp 2893-2903, issn 0008-5472, 11 p.Article

Cancer Prevention: From 1727 to Milestones of the Past 100 YearsLIPPMAN, Scott M; HAWK, Ernest T.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 13, pp 5269-5286, issn 0008-5472, 18 p.Article

Lung CancerHERBST, Roy S; HEYMACH, John V; LIPPMAN, Scott M et al.The New England journal of medicine. 2008, Vol 359, Num 13, pp 1367-1380, issn 0028-4793, 14 p.Article

Selenium effects on prostate cell growthsMENTER, David G; SABICHI, Anita L; LIPPMAN, Scott M et al.Cancer epidemiology, biomarkers & prevention. 2000, Vol 9, Num 11, pp 1171-1182, issn 1055-9965Article

Lung cancer chemoprevention : An integrated approachLIPPMAN, Scott M; SPITZ, Margaret R.Journal of clinical oncology. 2001, Vol 19, Num 18, pp 74s-82s, issn 0732-183X, SUPConference Paper

Cyclooxygenase-2 Gene Polymorphisms Reduce the Risk of Oral Premalignant LesionsXIA PU; LIPPMAN, Scott M; HUSHAN YANG et al.Cancer. 2009, Vol 115, Num 7, pp 1498-1506, issn 0008-543X, 9 p.Article

Advances in the biology of lung cancer chemopreventionHIRSCH, Fred R; LIPPMAN, Scott M.Journal of clinical oncology. 2005, Vol 23, Num 14, pp 3186-3197, issn 0732-183X, 12 p.Article

The cost of prostate cancer chemoprevention : A decision analysis modelSVATEK, Robert S; LEE, J. Jack; ROEHRBORN, Claus G et al.Cancer epidemiology, biomarkers & prevention. 2006, Vol 15, Num 8, pp 1485-1489, issn 1055-9965, 5 p.Article

Phase III prostate cancer prevention trials : Are the costs justified?THOMPSON, Ian M; TANGEN, Catherine M; KLEIN, Eric A et al.Journal of clinical oncology. 2005, Vol 23, Num 32, pp 8161-8164, issn 0732-183X, 4 p.Article

Identification of benzo(a)pyrene diol epoxide-binding DNA fragments using DNA immunoprecipitation techniqueZHENGDONG LIANG; LIPPMAN, Scott M; KAWABE, Atsushi et al.Cancer research (Baltimore). 2003, Vol 63, Num 7, pp 1470-1474, issn 0008-5472, 5 p.Article

Design considerations for efficient prostate cancer chemoprevention trialsLEE, J. Jack; LIEBERMAN, Ronald; SLOAN, Jeff A et al.Urology (Ridgewood, NJ). 2001, Vol 57, Num 4A, pp 205-212, issn 0090-4295Article

RRIG1 mediates effects of retinoic acid receptor β₂ on tumor cell growth and gene expression through binding to and inhibition of RhoALIANG, Zheng D; LIPPMAN, Scott M; WU, Tsung-Teh et al.Cancer research (Baltimore). 2006, Vol 66, Num 14, pp 7111-7118, issn 0008-5472, 8 p.Article

Implications of the Prostate Cancer Prevention trial: A decision analysis model of survival outcomesLOTAN, Yair; CADEDDU, Jeffrey A; LEE, J. Jack et al.Journal of clinical oncology. 2005, Vol 23, Num 9, pp 1911-1920, issn 0732-183X, 10 p.Article

The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces apoptosis via induction of 15-lipoxygenase-1 in colorectal cancer cellsHSI, Linda C; XIAOPEI XI; LOTAN, Reuben et al.Cancer research (Baltimore). 2004, Vol 64, Num 23, pp 8778-8781, issn 0008-5472, 4 p.Article

Prevention of prostate cancer with finasteride: US/European perspectiveTHOMPSON, Ian M; KLEIN, Eric A; LIPPMAN, Scott M et al.European urology. 2003, Vol 44, Num 6, pp 650-655, issn 0302-2838, 6 p.Article

Differential expression of cyclooxygenase-2 and its regulation by tumor necrosis factor-α in normal and malignant prostate cellsSUBBARAYAN, Vemparala; SABICHI, Anita L; LLANSA, Norma et al.Cancer research (Baltimore). 2001, Vol 61, Num 6, pp 2720-2726, issn 0008-5472Article

The role of neck dissection after chemoradiotherapy for oropharyngeal cancer with advanced nodal diseaseCLAYMAN, Gary L; JOHNSON, Chad Jeffery; MORRISON, William et al.Archives of otolaryngology, head & neck surgery. 2001, Vol 127, Num 2, pp 135-139, issn 0886-4470Conference Paper

Cost-Effectiveness of Prostate Cancer Chemoprevention : A Quality of Life-Years AnalysisSVATEK, Robert S; LEE, J. Jack; ROEHRBORN, Claus G et al.Cancer. 2008, Vol 112, Num 5, pp 1058-1065, issn 0008-543X, 8 p.Article

Oral cancer prevention and the evolution of molecular-targeted drug developmentLIPPMAN, Scott M; SUDBØ, Jon; WAUN KI HONG et al.Journal of clinical oncology. 2005, Vol 23, Num 2, pp 346-356, issn 0732-183X, 11 p.Article

Peroxisome proliferator-activated receptor-γ suppresses cyclooxygenase-2 expression in human prostate cellsSABICHI, Anita L; SUBBARAYAN, Vemparala; LLANSA, Norma et al.Cancer epidemiology, biomarkers & prevention. 2004, Vol 13, Num 11, pp 1704-1709, issn 1055-9965, 6 p., 1Article

Chronic Inflammation in Benign Prostate Tissue Is Associated with High-Grade Prostate Cancer in the Placebo Arm of the Prostate Cancer Prevention TrialGUREL, Bora; LUCIA, M. Scott; PESKOE, Sarah B et al.Cancer epidemiology, biomarkers & prevention. 2014, Vol 23, Num 5, pp 847-856, issn 1055-9965, 10 p.Article